At the same time, it cannot be excluded that due to intratumour heterogeneity, a tumour might initially be tested as TP53 wild-type on a TP53 wild-type region of the neoplasm, despite having a similar overall TP53 mutation load as tumours with readily detectable TP53 mutations. The gene discussed is TP53; the disease is neoplasm.